178 related articles for article (PubMed ID: 34069246)
1. Structural Insights into the Interaction of Filovirus Glycoproteins with the Endosomal Receptor Niemann-Pick C1: A Computational Study.
Igarashi M; Hirokawa T; Takadate Y; Takada A
Viruses; 2021 May; 13(5):. PubMed ID: 34069246
[TBL] [Abstract][Full Text] [Related]
2. Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by
Mittler E; Alkutkar T; Jangra RK; Chandran K
mBio; 2021 Jan; 12(1):. PubMed ID: 33436438
[TBL] [Abstract][Full Text] [Related]
3. Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1.
Wang H; Shi Y; Song J; Qi J; Lu G; Yan J; Gao GF
Cell; 2016 Jan; 164(1-2):258-268. PubMed ID: 26771495
[TBL] [Abstract][Full Text] [Related]
4. Filoviruses Use the HOPS Complex and UVRAG To Traffic to Niemann-Pick C1 Compartments during Viral Entry.
Bo Y; Qiu S; Mulloy RP; Côté M
J Virol; 2020 Jul; 94(16):. PubMed ID: 32493822
[TBL] [Abstract][Full Text] [Related]
5. Identification of filovirus entry inhibitors targeting the endosomal receptor NPC1 binding site.
Wang LL; Palermo N; Estrada L; Thompson C; Patten JJ; Anantpadma M; Davey RA; Xiang SH
Antiviral Res; 2021 May; 189():105059. PubMed ID: 33705865
[TBL] [Abstract][Full Text] [Related]
6. A Virion-Based Assay for Glycoprotein Thermostability Reveals Key Determinants of Filovirus Entry and Its Inhibition.
Bortz RH; Wong AC; Grodus MG; Recht HS; Pulanco MC; Lasso G; Anthony SJ; Mittler E; Jangra RK; Chandran K
J Virol; 2020 Aug; 94(18):. PubMed ID: 32611759
[TBL] [Abstract][Full Text] [Related]
7. Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection.
Gong X; Qian H; Zhou X; Wu J; Wan T; Cao P; Huang W; Zhao X; Wang X; Wang P; Shi Y; Gao GF; Zhou Q; Yan N
Cell; 2016 Jun; 165(6):1467-1478. PubMed ID: 27238017
[TBL] [Abstract][Full Text] [Related]
8. A Single Residue in Ebola Virus Receptor NPC1 Influences Cellular Host Range in Reptiles.
Ndungo E; Herbert AS; Raaben M; Obernosterer G; Biswas R; Miller EH; Wirchnianski AS; Carette JE; Brummelkamp TR; Whelan SP; Dye JM; Chandran K
mSphere; 2016; 1(2):. PubMed ID: 27303731
[TBL] [Abstract][Full Text] [Related]
9. Potential pharmacological strategies targeting the Niemann-Pick C1 receptor and Ebola virus glycoprotein interaction.
Morales-Tenorio M; Ginex T; Cuesta-Geijo MÁ; Campillo NE; Muñoz-Fontela C; Alonso C; Delgado R; Gil C
Eur J Med Chem; 2021 Nov; 223():113654. PubMed ID: 34175537
[TBL] [Abstract][Full Text] [Related]
10. Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies.
Bornholdt ZA; Ndungo E; Fusco ML; Bale S; Flyak AI; Crowe JE; Chandran K; Saphire EO
mBio; 2016 Feb; 7(1):e02154-15. PubMed ID: 26908579
[TBL] [Abstract][Full Text] [Related]
11. An exploration of conditions proposed to trigger the Ebola virus glycoprotein for fusion.
Fénéant L; Szymańska-de Wijs KM; Nelson EA; White JM
PLoS One; 2019; 14(7):e0219312. PubMed ID: 31276481
[TBL] [Abstract][Full Text] [Related]
12. Structural and Energetic Basis for Differential Binding of Ebola and Marburg Virus Glycoproteins to a Bat-Derived Niemann-Pick C1 Protein.
Igarashi M; Hirokawa T; Takada A
J Infect Dis; 2023 Nov; 228(Suppl 7):S479-S487. PubMed ID: 37119290
[TBL] [Abstract][Full Text] [Related]
13. Positive Selection Drives Evolution at the Host-Filovirus Interaction Surface.
Pontremoli C; Forni D; Cagliani R; Filippi G; De Gioia L; Pozzoli U; Clerici M; Sironi M
Mol Biol Evol; 2016 Nov; 33(11):2836-2847. PubMed ID: 27512112
[TBL] [Abstract][Full Text] [Related]
14. Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1.
Ng M; Ndungo E; Jangra RK; Cai Y; Postnikova E; Radoshitzky SR; Dye JM; Ramírez de Arellano E; Negredo A; Palacios G; Kuhn JH; Chandran K
Virology; 2014 Nov; 468-470():637-646. PubMed ID: 25310500
[TBL] [Abstract][Full Text] [Related]
15. Niemann-Pick C1 Heterogeneity of Bat Cells Controls Filovirus Tropism.
Takadate Y; Kondoh T; Igarashi M; Maruyama J; Manzoor R; Ogawa H; Kajihara M; Furuyama W; Sato M; Miyamoto H; Yoshida R; Hill TE; Freiberg AN; Feldmann H; Marzi A; Takada A
Cell Rep; 2020 Jan; 30(2):308-319.e5. PubMed ID: 31940478
[TBL] [Abstract][Full Text] [Related]
16. Novel cyclo-peptides inhibit Ebola pseudotyped virus entry by targeting primed GP protein.
Li Q; Ma L; Yi D; Wang H; Wang J; Zhang Y; Guo Y; Li X; Zhou J; Shi Y; Gao GF; Cen S
Antiviral Res; 2018 Jul; 155():1-11. PubMed ID: 29709562
[TBL] [Abstract][Full Text] [Related]
17. Filovirus entry: a novelty in the viral fusion world.
Hunt CL; Lennemann NJ; Maury W
Viruses; 2012 Feb; 4(2):258-75. PubMed ID: 22470835
[TBL] [Abstract][Full Text] [Related]
18. Two Distinct Lysosomal Targeting Strategies Afford Trojan Horse Antibodies With Pan-Filovirus Activity.
Wirchnianski AS; Wec AZ; Nyakatura EK; Herbert AS; Slough MM; Kuehne AI; Mittler E; Jangra RK; Teruya J; Dye JM; Lai JR; Chandran K
Front Immunol; 2021; 12():729851. PubMed ID: 34721393
[TBL] [Abstract][Full Text] [Related]
19. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
Brinkmann C; Nehlmeier I; Walendy-Gnirß K; Nehls J; González Hernández M; Hoffmann M; Qiu X; Takada A; Schindler M; Pöhlmann S
J Virol; 2016 Dec; 90(24):11075-11086. PubMed ID: 27707924
[TBL] [Abstract][Full Text] [Related]
20. Ebola virus entry requires the host-programmed recognition of an intracellular receptor.
Miller EH; Obernosterer G; Raaben M; Herbert AS; Deffieu MS; Krishnan A; Ndungo E; Sandesara RG; Carette JE; Kuehne AI; Ruthel G; Pfeffer SR; Dye JM; Whelan SP; Brummelkamp TR; Chandran K
EMBO J; 2012 Apr; 31(8):1947-60. PubMed ID: 22395071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
